SkyBridge Capital II’s Pfizer PFE Stock Holding History

SkyBridge Capital II’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-60,028	Closed	-$2.47M	–	19
2019 Q2	$2.47M	Sell	60,028 -53,213	-47%	-$2.11M	3.53%	9
2019 Q1	$4.56M	Sell	113,241 -15,272	-12%	-$612K	4.14%	5
2018 Q4	$5.32M	Sell	128,513 -34,445	-21%	-$1.43M	4.46%	2
2018 Q3	$6.81M	Sell	162,958 -10,418	-6%	-$401K	3.9%	6
2018 Q2	$5.97M	Sell	173,376 -40,841	-19%	-$1.4M	3.22%	18
2018 Q1	$7.21M	Sell	214,217 -77,303	-27%	-$2.66M	3.5%	10
2017 Q4	$10M	Sell	291,520 -60,570	-17%	-$2.07M	3.33%	15
2017 Q3	$11.9M	Sell	352,090 -74,994	-18%	-$2.41M	3.47%	11
2017 Q2	$13.6M	Sell	427,084 -63,460	-13%	-$2M	3.26%	17
2017 Q1	$15.9M	Sell	490,544 -18,689	-4%	-$589K	3.47%	16
2016 Q4	$15.7M	Buy	509,233 +56,766	+13%	+$1.73M	3.26%	18
2016 Q3	$14.5M	Buy	452,467 +43,176	+11%	+$1.44M	3.3%	15
2016 Q2	$13.7M	Buy	409,291 +126,815	+45%	+$4.05M	3.61%	6
2016 Q1	$7.94M	Buy	282,476 +66,234	+31%	+$1.89M	2.75%	25
2015 Q4	$6.62M	Buy	+216,242	New	+$6.8M	3.18%	16

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

SkyBridge Capital II's PFE Position: Q3 2019 in Review

SkyBridge Capital II sold out of Pfizer (PFE) in Q3 2019, closing a stake of 60,028 shares — an estimated $2.47M sold.

SkyBridge Capital II first reported a position in PFE in Q4 2015 and held it in 15 quarters. The position peaked at $15.9M in Q1 2017. 2,323 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

SkyBridge Capital II reported no remaining Pfizer position as of Q3 2019 after selling out during the quarter.
SkyBridge Capital II sold 60,028 Pfizer shares in Q3 2019, an estimated $2.47M.
SkyBridge Capital II first reported a position in Pfizer in Q4 2015 and held it in 15 quarters.
SkyBridge Capital II's Pfizer position peaked at $15.9M in Q1 2017.
2,323 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on SkyBridge Capital II's 13F filing for Q3 2019.